Non-Interventional Study to Review the Changes of Depression after First-Year of Tofacitinib Treatment in Rheumatoid Arthritis (XELJANZ®)

01/04/2021
05/02/2025
EU PAS number:
EUPAS40263
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A3921330 Final Protocol 02 April 2019_Public.pdf

English (7.96 MB - PDF) View document
Updated protocol

A3921330 Non Interventional Study Protocol_Amendment 1 V2_clean_18Jun2021_Public.pdf

First published: 19/11/2024
English (2.53 MB - PDF) View document
Study results
Study report
Study report

A3921330_NI STUDY REPORT_03Dec2024_Redacted.pdf

English (3.77 MB - PDF) View document

A3921330_NI STUDY REPORT ABSTRACT_03Dec2024_Redacted.pdf

English (237.71 KB - PDF) View document
Other information
Study, other information

A3921330_Abstract_18 June 2021

English (1.27 MB - PDF) View document